FDA approval-dnaprint wants this to add value to the product.. OVANOME works. They can tell non-responsiveness from these 2 drugs, but they want a clinical trial... just like a drug needs. They will want to earn money, just like a drug makes.. And DNAG will want to stop others from copying their technolopgy, just like drug companies want. Like a patent period and stop infringement. From dnaprint web sight.. Read about FDA approvals...(dnag does say that they may use the technology on a very small scale prior, but just a bit) http://www.dnaprint.com/welcome/productsandservices/pharmaceuticals/
DNAG's plan is very deliberate. DNAG is creating a new industry! Which will be centered around them. This is what I see.